BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 21452059)

  • 21. Gambogic acid inhibits angiogenesis through inhibiting PHD2-VHL-HIF-1α pathway.
    Lu N; Hui H; Yang H; Zhao K; Chen Y; You QD; Guo QL
    Eur J Pharm Sci; 2013 May; 49(2):220-6. PubMed ID: 23501055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory effect of HCPT on expression of HIF-1alpha and downstream genes in hypoxic human cervical SiHa cancer cells.
    Shi W; Yu S
    J Huazhong Univ Sci Technolog Med Sci; 2007 Oct; 27(5):586-9. PubMed ID: 18060642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Se-methylselenocysteine sensitizes hypoxic tumor cells to irinotecan by targeting hypoxia-inducible factor 1alpha.
    Chintala S; Tóth K; Cao S; Durrani FA; Vaughan MM; Jensen RL; Rustum YM
    Cancer Chemother Pharmacol; 2010 Oct; 66(5):899-911. PubMed ID: 20066420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The epigallocatechin gallate derivative Y
    Liao ZH; Zhu HQ; Chen YY; Chen RL; Fu LX; Li L; Zhou H; Zhou JL; Liang G
    J Ethnopharmacol; 2020 Sep; 259():112852. PubMed ID: 32278759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutant IkappaBalpha suppresses hypoxia-induced VEGF expression through downregulation of HIF-1alpha and COX-2 in human glioma cells.
    Kimba Y; Abe T; Wu JL; Inoue R; Fukiki M; Kohno K; Kobayashi H
    Oncol Res; 2005; 15(3):139-49. PubMed ID: 16050135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nuclear translocation and activation of YAP by hypoxia contributes to the chemoresistance of SN38 in hepatocellular carcinoma cells.
    Dai XY; Zhuang LH; Wang DD; Zhou TY; Chang LL; Gai RH; Zhu DF; Yang B; Zhu H; He QJ
    Oncotarget; 2016 Feb; 7(6):6933-47. PubMed ID: 26771844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of hypoxia inducible factor-1alpha (HIF-1alpha) decreases vascular endothelial growth factor (VEGF) secretion and tumor growth in malignant gliomas.
    Jensen RL; Ragel BT; Whang K; Gillespie D
    J Neurooncol; 2006 Jul; 78(3):233-47. PubMed ID: 16612574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chlorogenic acid inhibits hypoxia-induced angiogenesis via down-regulation of the HIF-1α/AKT pathway.
    Park JJ; Hwang SJ; Park JH; Lee HJ
    Cell Oncol (Dordr); 2015 Apr; 38(2):111-8. PubMed ID: 25561311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The radiosensitizing effect of CpG ODN107 on human glioma cells is tightly related to its antiangiogenic activity via suppression of HIF-1α/VEGF pathway.
    Liu D; Cao G; Cen Y; Liu T; Peng W; Sun J; Li X; Zhou H
    Int Immunopharmacol; 2013 Oct; 17(2):237-44. PubMed ID: 23791618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Arylsulfonamide KCN1 inhibits in vivo glioma growth and interferes with HIF signaling by disrupting HIF-1α interaction with cofactors p300/CBP.
    Yin S; Kaluz S; Devi NS; Jabbar AA; de Noronha RG; Mun J; Zhang Z; Boreddy PR; Wang W; Wang Z; Abbruscato T; Chen Z; Olson JJ; Zhang R; Goodman MM; Nicolaou KC; Van Meir EG
    Clin Cancer Res; 2012 Dec; 18(24):6623-33. PubMed ID: 22923450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LBH589 Inhibits Glioblastoma Growth and Angiogenesis Through Suppression of HIF-1α Expression.
    Yao ZG; Li WH; Hua F; Cheng HX; Zhao MQ; Sun XC; Qin YJ; Li JM
    J Neuropathol Exp Neurol; 2017 Dec; 76(12):1000-1007. PubMed ID: 29136455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nelfinavir down-regulates hypoxia-inducible factor 1alpha and VEGF expression and increases tumor oxygenation: implications for radiotherapy.
    Pore N; Gupta AK; Cerniglia GJ; Jiang Z; Bernhard EJ; Evans SM; Koch CJ; Hahn SM; Maity A
    Cancer Res; 2006 Sep; 66(18):9252-9. PubMed ID: 16982770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decursin promotes HIF-1α proteasomal degradation and immune responses in hypoxic tumour microenvironment.
    Ge Y; Yoon SH; Jang H; Jeong JH; Lee YM
    Phytomedicine; 2020 Nov; 78():153318. PubMed ID: 32896707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting HIF-1α by newly synthesized Indolephenoxyacetamide (IPA) analogs to induce anti-angiogenesis-mediated solid tumor suppression.
    Al-Ostoot FH; Sherapura A; V V; Basappa G; H K V; B T P; Khanum SA
    Pharmacol Rep; 2021 Oct; 73(5):1328-1343. PubMed ID: 33904146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural Optimization and Enhanced Prodrug-Mediated Delivery Overcomes Camptothecin Resistance in High-Risk Solid Tumors.
    Nguyen F; Guan P; Guerrero DT; Kolla V; Naraparaju K; Perry LM; Soberman D; Pressly BB; Alferiev IS; Chorny M; Brodeur GM
    Cancer Res; 2020 Oct; 80(19):4258-4265. PubMed ID: 32839252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CRLX101, an investigational camptothecin-containing nanoparticle-drug conjugate, targets cancer stem cells and impedes resistance to antiangiogenic therapy in mouse models of breast cancer.
    Conley SJ; Baker TL; Burnett JP; Theisen RL; Lazarus D; Peters CG; Clouthier SG; Eliasof S; Wicha MS
    Breast Cancer Res Treat; 2015 Apr; 150(3):559-67. PubMed ID: 25833208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topotecan inhibits vascular endothelial growth factor production and angiogenic activity induced by hypoxia in human neuroblastoma by targeting hypoxia-inducible factor-1alpha and -2alpha.
    Puppo M; Battaglia F; Ottaviano C; Delfino S; Ribatti D; Varesio L; Bosco MC
    Mol Cancer Ther; 2008 Jul; 7(7):1974-84. PubMed ID: 18645007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiangiogenic activity of phthalides-enriched Angelica Sinensis extract by suppressing WSB-1/pVHL/HIF-1α/VEGF signaling in bladder cancer.
    Chen MC; Hsu WL; Chang WL; Chou TC
    Sci Rep; 2017 Jul; 7(1):5376. PubMed ID: 28710377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-tumor activity of the novel hexahydrocannabinol analog LYR-8 in Human colorectal tumor xenograft is mediated through the inhibition of Akt and hypoxia-inducible factor-1α activation.
    Thapa D; Kang Y; Park PH; Noh SK; Lee YR; Han SS; Ku SK; Jung Y; Kim JA
    Biol Pharm Bull; 2012; 35(6):924-32. PubMed ID: 22687485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase 1 evaluation of EZN-2208, a polyethylene glycol conjugate of SN38, in children adolescents and young adults with relapsed or refractory solid tumors.
    Norris RE; Shusterman S; Gore L; Muscal JA; Macy ME; Fox E; Berkowitz N; Buchbinder A; Bagatell R
    Pediatr Blood Cancer; 2014 Oct; 61(10):1792-7. PubMed ID: 24962521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.